Benzinga's M&A Chatter for Wednesday August 19, 2015

The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday August 19, 2015:

:

United Therapeutics Corporation

announced Wednesday that it has entered into an agreement to sell its Rare Pediatric Disease Priority Review Voucher to a subsidiary of AbbVie Inc.

for $350 million in cash. The voucher was awarded by the FDA under a provision that encourages development of new drugs and biologics for the prevention and treatment of rare pediatric diseases. United Therapeutics closed at $167.68 on Wednesday, up $0.10.

:

CyberArk

shares rose Wednesday on a report from

that IBM

and FireEye

could each look at CyberArk as a potential takeover target. FireEye has been mentioned as an acquisition target for IBM in the past. CyberArk closed at $61.63 Wednesday, a gain of 3.5%.

:

Suja Life LLC. announced Wednesday, an investment and distribution partnership with The Coca‑Cola Company

. Sujua says Coca-Cola's minority investment will increase the availability of Suja. The Merchant Banking Division of Goldman Sachs has also made a minority investment in Suja.

reported that Coca-Cola is said to have option to acquire Suja as part of the deal. Coca-Cola shares fell 1.26% Wednesday, closing at $40.78.

:

Solera Holdings Inc.

has attracted interest from private equity firms and is working with a financial advisor, according to sources as reported by

on Wednesday. Solera is said to have approached Pamplona Capital Management and Thoma Bravo. A spokesperson for Thoma Bravo, declined comment. While Solera and Pamplona did not immediately respond to requests for comment, according to

. Solera shares rose $0.15 Wednesday, closing at $48.65.